CSL gets European OK for Novartis flu vaccines purchase; GSK's malaria vax may pick up key approval Friday;

> CSL received regulatory approval from the European Commission on its deal to buy Novartis' ($NVS) flu vaccine business, though the deal has not closed yet. Report

> European regulators could recommend GlaxoSmithKline's ($GSK) malaria vaccine--the world's first such shot--on Friday, Reuters reported. Story

> Focusing on blocking the disease's transmission process, a professor from Oklahoma University is working to develop a malaria vaccine. Report

And Finally... Portland State University virologists discovered how to neutralize viruses by coating them in silica and then bring them back to life by removing the coat--the team dubbed them "zombie viruses." Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.